Abstract
Screening for colorectal cancer aims at the early detection of early cancer stages in individuals in a defined, otherwise healthy population. In randomized controlled trials it was possible to achieve a clinically and statistically significant reduction of colorectal cancer mortality for those citizens who participated in a quality assured screening program. It is one of the most pertinent goals of quality assurance measures to attain this success in routine settings. As Sir Muir Gray pointed out: All screening programs do harm, some do good as well [1]. Since screening of colorectal cancer is not just the test such as a test for occult blood, quality assurance has to cover all relevant steps of the program (”screening chain”).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
